Clinical Trials Logo

Clinical Trial Summary

Myofascial pelvic pain (MFPP) caused by myofascial trigger points (MTrPs) is a major contributor of female chronic pelvic pain. However, the effect of the patient's self-myofascial release (SMFR) is not clear. Current study is to investigate the effect of SMFR combined with biofeedback and electrical stimulation (BES) therapy compared with BES alone in patients with MFPP.


Clinical Trial Description

68 patients was enrolled and randomly allocated into two groups: BES-SMFR group (n=34) and BES group (n=34). Every patient received 4 weeks treatment, and was evaluated at baseline (T0), 4-week post-intervention (T4) and 12-week follow-up (T12). The primary outcome was pain intensity. The secondary outcomes were degree in activation of MTrPs, surface electromyography (sEMG) levels, and Patient Global Impression of Improvement (PGI-I). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04746352
Study type Interventional
Source Zhongda Hospital
Contact
Status Completed
Phase N/A
Start date September 1, 2017
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT01616992 - Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study N/A
Recruiting NCT05354869 - Transvaginal Electrical Stimulation for Myofascial Pelvic Pain N/A
Completed NCT03008382 - Interstitial Cystitis: Examination of the Central Autonomic Network Phase 4
Active, not recruiting NCT01905137 - Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain N/A